The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Tamiflu

6 milligram(s)/millilitre Powder for oral suspension

Roche Registration GmbHEU/1/02/222/005

Main Information

Trade NameTamiflu
Active SubstancesOseltamivir phosphate
Strength6 milligram(s)/millilitre
Dosage FormPowder for oral suspension
Licence HolderRoche Registration GmbH
Licence NumberEU/1/02/222/005

Group Information

ATC CodeJ05AH02 oseltamivir

Status

Authorised/WithdrawnAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back